Bahrami, Afsane <br/><br/>
The therapeutic potential of targeting the BRAF mutation in patients with colorectal cancer.  [electronic resource] 

 -  Journal of cellular physiology  Mar 2018 
 - 2162-2169 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1097-4652 
<br/><br/><label>Standard No.: </label>10.1002/jcp.25952  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Substitution--genetics<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carbamates--therapeutic use<br/>Cinnamates--therapeutic use<br/>Colorectal Neoplasms--drug therapy<br/>Drug Resistance, Neoplasm--genetics<br/>ErbB Receptors--antagonists & inhibitors<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Humans<br/>Imidazoles--therapeutic use<br/>Indoles--therapeutic use<br/>MAP Kinase Kinase Kinases--antagonists & inhibitors<br/>Oximes--therapeutic use<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Piperazines--therapeutic use<br/>Proto-Oncogene Proteins B-raf--antagonists & inhibitors<br/>Sulfonamides--therapeutic use<br/>Vemurafenib